echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Urinary System > The effect of exercise on the disease progression of patients with localized prostate cancer

    The effect of exercise on the disease progression of patients with localized prostate cancer

    • Last Update: 2021-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is from the NEJM Journal Watch Impact of Exercise on Disease Progression in Men with Localized Prostate Cancer.
    Comment on the impact of the movement on the disease progression of patients with localized prostate cancer.
    Author: Robert Dreicer, MD, MS, MACP, FASCOERASE Trial Finding 12 Weekly high-intensity interval training is beneficial
    .

    More and more low-risk prostate cancer patients are undergoing active monitoring instead of immediate local radical treatment, but 55% of them will receive definitive treatment within 10 years
    .

    Considering the disease biology and age range of this population, it is not surprising that the risk of cardiovascular disease-related death in these patients is three times the risk of prostate cancer-specific death
    .

    In order to improve cardiovascular health and delay the progression of prostate cancer, researchers evaluated the impact of high-intensity interval training (HIIT) on low- to intermediate-risk patients who are suitable for active monitoring
    .

    In a phase 2 trial, patients were randomly divided into two groups, one group underwent HIIT (exercise three times a week under the supervision of others for 12 weeks), and the other group received conventional treatment
    .

    This trial allows patients to cross groups at 12 weeks
    .

    The main outcome was the peak oxygen consumption during the graded exercise test; the secondary outcome was the change in prostate-specific antigen (PSA) parameters
    .

    During the 20-month period, 56 men were randomized and their median age was 63 years
    .

    The compliance rate in the HIIT group was 96%
    .

    Compared with the conventional treatment group, the peak oxygen consumption of the HIIT group was significantly improved, and the total PSA level was reduced, and the rate of PSA rise slowed down; there was no difference in PSA doubling time and testosterone levels between the two groups
    .

    Comment As stated in a review, although the ERASE trial is small, the dropout rate is extremely low (3 patients)
    .

    The comment writer also pointed out that although it is ethical to allow cross-groups at 12 weeks, it will complicate subsequent comparisons
    .

    Importantly, the comment writer pointed out that for patients who will eventually need treatment for prostate cancer and/or will eventually develop cardiovascular disease, the benefits shown by the experimental group (including improvements in upper body strength and lower body flexibility) may be “previous” Improved the patient’s health"
    .

    Other similar trials (INTERVAL-GAP4) with sufficient statistical power to assess the impact on overall survival are ongoing
    .

    Commented article [1] Kang DW et al.
    Effects of exercise on cardiorespiratory fitness and biochemical progression in men with localized prostate cancer under active surveillance: The ERASE randomized clinical trial.
    JAMA Oncol 2021 Aug 19; [e-pub].
    (https ://doi.
    org/10.
    1001/jamaoncol.
    2021.
    3067)[2] Vapiwala N.
    The power of exercise to influence cardiovascular and oncologic outcomes — Survival of the fittest.
    JAMA Oncol 2021 Aug 19; [e-pub].
    (https: //doi.
    org/10.
    1001/jamaoncol.
    2021.
    3065) NEJM Journal Collection NEJM Journal Watch (NEJM Journal Watch) is published by NEJM Group.
    Internationally renowned doctors are invited to comment on important papers in the medical field to help doctors understand and use the latest developments
    .

    "NEJM Frontiers in Medicine" is translated several times a week, published on the app and official website, and selected 2-3 articles are published on WeChat
    .

    Copyright information This article was translated, written or commissioned by the "NEJM Frontiers of Medicine" jointly created by the Jiahui Medical Research and Education Group (J-Med) and the "New England Journal of Medicine" (NEJM)
    .

    The Chinese translation of the full text and the included diagrams are exclusively authorized by the NEJM Group
    .

    If you need to reprint, please leave a message or contact nejmqianyan@nejmqianyan.
    cn
    .

    Unauthorized translation is an infringement, and the copyright owner reserves the right to pursue legal liabilities
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.